IDRC and the Minister of International Development, the Honourable Harjit Sajjan, are pleased to announce that Dr. Dorothy Nyambi has been appointed as Chairperson of IDRC’s Board of Governors, Nurjehan Mawani has been appointed as governor and Gilles Rivard, Purnima Mane and Akwasi Aidoo have been reappointed as governors.
Zulfiqar A. Bhutta, a long-time IDRC grantee, has been awarded the John Dirks Canada Gairdner 2022 Global Health Award “for the development and evaluation of evidence-based interventions in child and maternal health for marginalized populations, focusing on outcomes for the ‘first thousand days’ of life.”
For many people, the raison d’être of global health is the achievement of health equity for all people worldwide. Reaffirming this view is the United Nations’ Sustainable Development Goal 3, which seeks to “ensure healthy lives and promote well-being for all at all ages.” Yet, after decades of programming and billions of dollars invested in global health, alarming health inequities persist across and within countries. The current COVID-19 pandemic has further exacerbated these health inequities, underscoring the need for the field of global health to do more and to do better.
This project will produce evidence for public policies in response to growing economic austerity, ongoing structural economic change and social discontent in the Middle East and North Africa, including Egypt, Jordan, Lebanon, Morocco, Sudan and Tunisia.
In the context of climate change and COVID-19, three IDRC-funded research projects offer a unique perspective on the opportunities and challenges facing women working in Africa’s agricultural value chains.
This project will contribute to addressing sexual and reproductive health (SRH) and gender-based violence (GBV)-related morbidity and mortality among migrants residing in Morocco, particularly among women and girls.
In March 2020, the World Health Organization declared a pandemic due to the emergence of SARS-CoV2, which causes COVID-19, a potentially lethal respiratory infection. To date, apart from the novel Molnupiravir and Ritonavir, there are no orally or nasally administered antiviral agents to prevent or treat SARS-CoV2 infections.
With funding from IDRC, a research team from the Prospective Urban Rural Epidemiology (PURE) study, a large international population research effort coordinated by McMaster University’s Population Health Research Institute (PHRI), is studying why some people get COVID-19 and others do not.
“Rethinking Partnership Paradigms in Global Health” is the theme of the Canadian Conference on Global Health 2021 (CCGH 2021) taking place from November 24 to 26. It will be a hybrid event with most attendees attending virtually and small in-person sessions at the Delta Hotel in Ottawa.